Page 37 - Genomic Medicine in Emerging Economies

26 CHAPTER 2: Taking Genomics From the Bench to the Bedside in Developing Countries

Manolio, T.A., Abramowicz, M., Al-Mulla, F., Anderson, W., Balling, R., Berger, A.C., et al., 2015.
Global implementation of genomic medicine: we are not alone. Sci. Transl. Med. 7 (290),
290ps13.
Manolio, T.A., Chisholm, R.L., Ozenberger, B., Roden, D.M., Williams, M.S., Wilson, R., et al.,
2013. Implementing genomic medicine in the clinic: the future is here. Genet. Med. 15 (4),
258–267.
Manrai, A.K., Funke, B.H., Rehm, H.L., Olesen, M.S., Maron, B.A., Szolovits, P., et al., 2016. Genetic
misdiagnoses and the potential for health disparities. N. Engl. J. Med. 375 (7), 655–665.
O’Daniel, J.M., Berg, J.S., 2016. A missing link in the bench-to-bedside paradigm: engaging regula-
tory stakeholders in clinical genomics research. Genome Med. 8 (1), 95.
Pang, T., 2013. Genomics for public health improvement: relevant international ethical and policy
issues around genome-wide association studies and biobanks. Public Health Genomics 16
(1–2), 69–72.
Parker, M., Kwiatkowski, D.P., 2016. The ethics of sustainable genomic research in Africa. Genome
Biol. 17, 44.
Penchaszadeh, V.B., 2015. Ethical issues in genetics and public health in Latin America with a focus
on Argentina. J. Community Genet. 6 (3), 223–230.
Sirisena, N.D., Neththikumara, N., Wetthasinghe, K., Dissanayake, V.H.W., 2016. Implementation
of genomic medicine in Sri Lanka: initial experience and challenges. Appl. Transl. Genom. 9,
33–36.
Zimmern, R.L., Khoury, M.J., 2012. The impact of genomics on public health practice: the case for
change. Public Health Genomics. 15 (3–4), 118–124.